When people search for the IVF success rate in Nigeria, they usually want one clear percentage. Unfortunately, a percentage without context can create more confusion than clarity. One clinic may report a pregnancy rate per embryo transfer, another may report live births per egg collection, and another may combine patients of different ages or include donor-egg cycles. Those figures do not describe the same outcome.
The most useful question is therefore not only, “What is the success rate?” It is also, “Success measured as what, for whom, and at which stage of treatment?”
Nordica publishes information about its IVF success rates and explains that outcomes vary with age, diagnosis, egg and sperm quality, embryo development, uterine health and other individual factors. This article goes a step further by explaining how to read any IVF figure responsibly and why a cycle may be unsuccessful even when treatment has been carefully planned.
Is there one national IVF success rate for Nigeria?
The sources reviewed for this article did not provide a single, current, nationally standardised and publicly accessible live-birth rate covering all fertility clinics in Nigeria. Nigerian studies can tell us what happened in particular hospitals or groups of patients, but their results should not be presented as the success rate for the whole country.
For example, a ten-year review from a Nigerian tertiary hospital reported a clinical pregnancy rate and other outcomes within its own study population. Such research is valuable, but the patients, treatment years, cycle types and outcome definitions may differ from those of a private fertility centre. Direct comparison can therefore be misleading.
International registries show why definitions matter. The UK’s Human Fertilisation and Embryology Authority reported that in 2024, the average birth rate per embryo transferred using patients’ own eggs was highest among patients aged 18 to 34 and much lower among those aged 43 to 44. These are UK data, not Nigerian predictions, but they demonstrate the strong relationship between the age of the egg and IVF outcome. See the HFEA’s 2024 fertility treatment figures.
Five questions to ask when a clinic quotes an IVF success rate
1. Does “success” mean a positive test, pregnancy or live birth?
A positive pregnancy test shows that the pregnancy hormone hCG has been detected. A clinical pregnancy is usually confirmed later by ultrasound. A live birth is the delivery of a living baby. These are different endpoints, and the percentage normally becomes smaller as the endpoint moves from a positive test to a live birth.
2. What is the denominator?
The rate may be calculated per cycle started, per egg retrieval, per embryo transfer or cumulatively after all fresh and frozen embryos from one retrieval have been used. A per-transfer rate leaves out cycles that did not reach transfer, so it can look higher than a per-cycle-start rate.
3. Are the results separated by age?
Combining a 30-year-old patient’s results with those of a 43-year-old patient can hide a major difference in prognosis. The age of the person whose eggs are used is especially important. Nordica’s related article on age and IVF success rates explains this relationship in more detail.
4. Were patients using their own eggs or donor eggs?
Donor eggs usually come from younger, screened donors. That can substantially change the expected outcome for an older recipient. A clinic-wide figure that combines own-egg and donor-egg cycles is difficult to apply to one patient.
5. Is the figure for one transfer or the complete treatment journey?
One ovarian stimulation cycle can produce more than one embryo. If suitable embryos are frozen, later frozen embryo transfers may provide additional chances without another egg retrieval. A cumulative live-birth rate captures more of that journey than the result of the first transfer alone.
Why can an IVF cycle be unsuccessful?
IVF is a sequence, not a single event. Eggs must develop, be retrieved and mature. Fertilisation must occur. An embryo must continue developing, implant in the womb and progress through pregnancy. A cycle can stop at any of these stages, and sometimes there is no single explanation.
The ovaries produce fewer eggs than expected
Some patients have a lower ovarian reserve or respond less strongly to stimulation medication. Age, previous ovarian surgery, endometriosis and individual biology can influence response. Ovarian reserve tests help doctors estimate the likely response, but they cannot guarantee the number or quality of eggs that will be collected.
Some retrieved eggs are immature or do not fertilise
Not every follicle contains an egg, not every egg is mature, and not every mature egg fertilises. Fertilisation can be affected by egg factors, sperm factors or both. Where clinically appropriate, IVF may be combined with ICSI, in which one sperm is injected into an egg. ICSI can help overcome specific fertilisation problems, especially severe male-factor infertility, but it cannot correct poor egg quality or guarantee a healthy embryo. Read Nordica’s overview of IVF and ICSI treatment.
Embryos stop developing
Early embryos undergo rapid cell division. Some stop developing before they reach the stage required for transfer or freezing. One important reason is a chromosome-number problem in the embryo, known as aneuploidy. The likelihood of aneuploid embryos rises as eggs age, which helps explain lower implantation and live-birth rates and higher miscarriage rates in older age groups.
An embryo does not implant
Even an embryo that looks suitable under a microscope may not implant. Appearance cannot reveal every biological or chromosomal issue. The womb lining, uterine cavity and timing of progesterone exposure also matter, although implantation is complex and a single failed transfer does not automatically prove that the womb is “rejecting” embryos.
Fibroids that distort the uterine cavity, endometrial polyps, adhesions, some congenital uterine differences and fluid in a damaged fallopian tube may affect implantation or pregnancy. Tests should be selected from the patient’s history and findings, not ordered as an unlimited package after every unsuccessful attempt.
A pregnancy begins but ends in miscarriage
IVF cannot remove every cause of miscarriage. Chromosomal abnormalities are a major cause of early pregnancy loss, and risk increases with egg age. Uterine conditions, some endocrine disorders and certain medical conditions may also contribute. Patients with repeated losses or repeated unsuccessful treatment may benefit from a structured review through Nordica’s failed cycle and pregnancy loss clinic.
Sperm-related factors affect fertilisation or embryo development
Low sperm concentration, reduced movement, abnormal morphology, obstruction, ejaculation problems and genetic or hormonal conditions can contribute to infertility. A semen analysis is an essential starting test, but an abnormal result often needs confirmation and clinical interpretation. Both partners should be assessed at the same time, as recommended by the AUA and ASRM male infertility guideline.
Health and lifestyle factors influence the background risk
Smoking, very high or very low body weight, heavy alcohol use and uncontrolled medical conditions can affect reproductive health. Improving general health is worthwhile, but patients should be wary of claims that one food, supplement or stress-reduction method can guarantee implantation. Stress can make treatment harder to cope with; an unsuccessful cycle is not proof that a patient “did not relax enough.”
Medication timing or an unexpected clinical event changes the cycle
IVF medication is carefully timed. A missed dose, an incorrectly administered trigger injection or premature ovulation can affect egg collection. Clinics provide precise instructions because different injections have different purposes. Nordica’s step-by-step IVF guide can help patients understand where medication fits into the process.
Does one failed IVF cycle mean IVF will never work?
No. A single unsuccessful cycle provides information, but it does not by itself predict that every later cycle will fail. At the same time, automatically repeating the identical plan may not be appropriate. The next step should depend on what happened during the cycle and the patient’s overall prognosis.
A post-cycle review may examine:
the medication protocol and ovarian response;
the number of follicles, eggs retrieved and mature eggs;
fertilisation method and fertilisation rate;
embryo development and whether embryos were available for freezing;
transfer conditions and uterine findings;
semen results and any relevant male evaluation;
age, diagnosis, previous treatment and pregnancy history;
whether a different protocol, donor eggs, donor sperm or another route is medically reasonable.
Patients should also ask what evidence supports any proposed IVF add-on. Some extra tests or treatments have uncertain benefit for improving live birth. The HFEA treatment add-ons guide is a useful independent starting point for that discussion.
How can patients improve their chance of an informed IVF journey?
No patient can control every part of IVF, but good decisions can reduce avoidable uncertainty. Seek assessment early, ensure both partners are evaluated, take medication exactly as instructed, disclose all medicines and supplements, avoid smoking, manage existing health conditions, and ask the clinic to explain outcomes using a denominator that applies to you.
Most importantly, ask for an individual prognosis rather than a marketing promise. A responsible fertility specialist should be able to explain what is known, what remains uncertain and what the next decision would be if the first plan does not work.
Frequently asked questions
What is a good IVF success rate in Nigeria?
There is no responsible universal cutoff. A useful rate must state the outcome, denominator, age group, egg source and treatment period. A live-birth rate per cycle started is not interchangeable with a pregnancy rate per embryo transfer.
Why does IVF fail with a “good” embryo?
Embryo grading mainly describes appearance and development. It cannot detect every chromosomal or biological problem, and implantation also depends on several embryo and uterine factors. A good grade improves selection but does not guarantee a baby.
How soon can IVF be tried again?
Timing depends on physical recovery, ovarian response, complications, emotional readiness and whether further evaluation is needed. The treating specialist should review the completed cycle before recommending a date.
Can IVF success be guaranteed?
No. Any clinic that guarantees pregnancy or a baby is oversimplifying a complex medical treatment.
